XML 33 R22.htm IDEA: XBRL DOCUMENT v3.19.1
Asset Acquisitions and Contingent Consideration (Tables)
3 Months Ended
Mar. 31, 2019
Business Combinations [Abstract]  
Schedule of IPR&D Expense

The Company recorded the following IPR&D expense on the condensed consolidated statements of operations (in thousands):

 

 

 

Three months ended March 31,

 

 

 

2019

 

 

2018

 

GB001

 

$

 

 

$

19,148

 

Other Programs

 

 

1,000

 

 

 

1,750

 

Total in process research and development

 

$

1,000

 

 

$

20,898